Sartorius (FRA:SRT3) received a €125.00 ($154.32) target price from equities research analysts at UBS Group in a research note issued on Friday, www.boersen-zeitung.de reports. The firm currently has a “buy” rating on the stock. UBS Group’s price objective would suggest a potential upside of 14.26% from the stock’s previous close.
SRT3 has been the subject of a number of other reports. Kepler Capital Markets set a €78.00 ($96.30) price target on Sartorius and gave the stock a “neutral” rating in a research report on Thursday, January 4th. Berenberg Bank set a €85.00 ($104.94) target price on Sartorius and gave the stock a “buy” rating in a research report on Wednesday, December 6th. Hauck & Aufhaeuser set a €60.00 ($74.07) target price on Sartorius and gave the stock a “sell” rating in a research report on Thursday, October 26th. Commerzbank set a €76.00 ($93.83) target price on Sartorius and gave the stock a “neutral” rating in a research report on Wednesday, January 10th. Finally, set a €78.00 ($96.30) target price on Sartorius and gave the stock a “neutral” rating in a research report on Thursday, October 26th. Three analysts have rated the stock with a sell rating, five have assigned a hold rating and three have issued a buy rating to the stock. The company presently has a consensus rating of “Hold” and a consensus target price of €83.18 ($102.69).
Shares of Sartorius (FRA:SRT3) opened at €109.40 ($135.06) on Friday. The stock has a market capitalization of $7,910.00 and a price-to-earnings ratio of 73.92. Sartorius has a 52-week low of €68.89 ($85.05) and a 52-week high of €109.40 ($135.06).
TRADEMARK VIOLATION NOTICE: “Sartorius (SRT3) Given a €125.00 Price Target by UBS Group Analysts” was originally reported by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are reading this story on another website, it was illegally copied and republished in violation of US and international trademark & copyright legislation. The correct version of this story can be read at https://www.dispatchtribunal.com/2018/02/23/sartorius-srt3-given-a-125-00-price-target-by-ubs-group-analysts.html.
Sartorius Company Profile
Sartorius Aktiengesellschaft provides laboratory and process technologies and equipment worldwide. The company operates through two divisions, Bioprocess Solutions, and Lab Products & Services. The Bioprocess Solutions division offers products, technologies, and services ranging from fermentation, cell cultivation, filtration, and purification to media storage and transportation for the biopharmaceutical industry.
Receive News & Ratings for Sartorius Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sartorius and related companies with MarketBeat.com's FREE daily email newsletter.